$154 Million is the total value of ARCH Venture Management, LLC's 7 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EQRX, INC. | $80,664,533 | +19.4% | 36,335,375 | 0.0% | 52.39% | +25.5% | ||
| VERV | VERVE THERAPEUTICS, INC. | $26,636,807 | -29.3% | 2,008,809 | 0.0% | 17.30% | -25.6% | |
| ERASCA, INC. | $21,779,441 | -28.6% | 11,055,554 | 0.0% | 14.15% | -24.9% | ||
| DNLI | DENALI THERAPEUTICS, INC. | $14,312,042 | -30.1% | 693,749 | 0.0% | 9.30% | -26.5% | |
| GOSS | New | GOSSAMER BIO, INC. | $6,708,967 | – | 8,055,916 | +100.0% | 4.36% | – |
| UNITY BIOTECHNOLOGY, INC. | $2,411,561 | -5.9% | 1,004,817 | 0.0% | 1.57% | -1.0% | ||
| OMIC | SINGULAR GENOMICS SYSTEMS, INC. | $1,447,391 | -54.1% | 3,798,926 | 0.0% | 0.94% | -51.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RUBIUS THERAPEUTICS, INC. | 12 | Q3 2022 | 65.5% |
| EQRX, INC. | 8 | Q3 2023 | 52.4% |
| ERASCA, INC. | 8 | Q3 2023 | 18.8% |
| VERVE THERAPEUTICS, INC. | 8 | Q3 2023 | 23.3% |
| CHIASMA INC | 8 | Q3 2020 | 25.7% |
| SINGULAR GENOMICS SYSTEMS, INC. | 8 | Q3 2023 | 4.6% |
| KURA ONCOLOGY INC | 7 | Q2 2020 | 27.6% |
| KARUNA THERAPEUTICS, INC. | 6 | Q1 2023 | 52.8% |
| DENALI THERAPEUTICS, INC. | 6 | Q3 2023 | 28.6% |
| SYROS PHARMACEUTICALS INC | 5 | Q3 2020 | 43.8% |
View ARCH Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-27 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View ARCH Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.